Global Markets and Technologies for Molecular Imaging Devices

NEW YORK, Dec.迷你倉 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:Global Markets and Technologies for Molecular Imaging Devices.reportlinker.com/p01923023/Global-Markets-and-Technologies-for-Molecular-Imaging-Devices.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_ImagingSTUDY GOALS AND OBJECTIVESThe objectives of this study are to present a comprehensive look at molecular imaging devices used for diagnostic purposes, present global market measurements of both the overall market and all possible market segments as well as forecast market and segment growth over the next five years.REASONS FOR STUDYThis BCC Research study is presented to provide an in-depth market analysis of the molecular imaging device industry. The study includes an analysis of the factors driving the growth, challenges affecting the industry, and opportunities that participants can tap within the forecast period. The report also reviews the competitive landscape, leading pipeline products, pricing and technology offerings.Key geographies covered include the U.S., Canada, the U.K., Germany, France, Italy, Spain, Japan, China, India and Australia. Key segments covered are planar scintillation cameras, PET, PET-CT, SPECT and SPECT-CT systems. This report will benefit the market participants in making more informed business decisions; in developing business strategies; in market entry and market expansion strategies; and in understanding the overall market landscape for molecular imaging devices. This report also examines the impact of reimbursement cuts and a declining overall economy on molecular imaging market progression.SCOPE OF STUDYThis report is a comprehensive business tool designed to provide an in-depth look at molecular imaging devices for various applications. The geographic scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants and trends for the future.Categories discussed in the report include:-- Planar scintillation cameras.-- PET.-- PET-CT.-- SPECT.-- SPECT-CT.Applications discussed in the report include:-- Oncology.-- Cardio and vascular.-- Neurology.-- Others (brain imaging, tumors, Alzheimer's, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging).All categories are discussed in detail, describing each segment, identifying current products in the market, measuring market size, identifying market drivers, forecasting for 2013 through 2018 and assessing the competitors and competitor market shares. For country-level breakdown of segments, only the base year 2013 and projections through 2018 are shown in the data tables.The market evaluated in this study pertains to new nuclear medicine and PET imaging systems that are developed and approved for human clinical use. The market sizing only takes into account the new equipment. Options/upgrades or refurbished/remarketed equipment have not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services, including contrast agents, radiopharmaceuticals, licensing fees, cyclotrons, radiotherapy equipment, and mobile imaging devices have been excluded from the study. Also, integrated PET/MRI systems are not accounted for in forecasts pertaining to the market segment.METHODOLOGY AND INFORMATION SOURCESThe information and analysis presented in this BCC Research report are based on primary research in the form of interviews with manufacturers, healthcare providers and thought leaders in the healthcare field. Background information was obtained from various. government agencies, business and medical journals, trade magazines, and interviews with opinion leaders, the research and development (R&D) community, product managers, marketing managers and government officials.Key information from published literature was used to conduct interviews with more than 20 industry participants to validate and obtain expert opinions on current and future trends in the computed tomography market. Interviews were the primary basis for the development of market size. A bottom-up approach was utilized, looking at market metrics country-wise, using information at the country level to look at dynamics, and their impact on revenues and growth. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulate market projections.Input from primary research was applied to market data to establish the market metrics. Base year revenues were employed in conjunction with average pricing to establish unit shipments, and forecasts were established using quantitative market input, and qualitative trends that impact growth rate.All market data pertain to the global market at the manufacturer level. Data are expressed in current U.S. dollars. The base year was 2013. Historical data are provided for 2012 and forecast data are provided for 2018. Historical, base year and forecast data are provided for each market segment and sub segment. Market shares are provided for each market segment for the 2013 base year. The mathematical model utilizes historical, base year, weighted average selling price (WASP) estimates to draw market projections. The study implements aggregate calculations and estimates and is unable to take into account the unexpected shifts in demand that result from unforeseen prices changes, regulatory changes, or sudden changes in patient and end-user characteristics.ANALYST CREDENTIALSSmruti Munshi is a research analyst who has specialized in the medical technologies space for the last five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets ranging from market insights, and industry overviews to comprehensive marketing and technology-oriented custom consulting. Ms. Munshi has an M.S. in Biomedical Engineering and a B.S. in Instrumentation and Control Engineering.REPORT HIGHLIGHTSThe global market for molecular imaging devices was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.This report provides:-- An overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward more personalized forms of treatment.-- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.-- Examination of factors driving growth, market figures related to the current value of molecular imaging equipment, market shares, and key players.-- Reviews of the competitive landscape, leading pipeline products, pricing, and technology offerings.-- Identification of the types of molecular imaging devices, including stand-alone planar imaging, PET, PET-CT, SPECT, and SPECT-CT.-- Comprehensive company profiles of major manufacturers.TABLE OF CONTENTSCHAPTER 1 INTRODUCTION 2STUDY GOALS AND OBJECTIVES 2REASONS FOR STUDY 2SCOPE OF STUDY 2METHODOLOGY AND INFORMATION SOURCES 3ANALYST CREDENTIALS 4RELATED BCC RESEARCH REPORTS 4BCC RESEARCH ONLINE SERVICES 4DISCLAIMER 4CHAPTER 2 SUMMARY 6SUMMARY TABLE GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH2018 ($ MILLIONS) 7SUMMARY FIGURE GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES,2012-2018 ($ MILLIONS) 7CHAPTER 3 AN INTRODUCTION TO MOLECULAR IMAGING 11RADIOPHARMACEUTICALS 13TABLE 1 CURRENT PROCESSORS OF MO-99 BY COUNTRY 14AN INTRODUCTION TO MOLECULAR IMAGING DEVICES 14POSITRON EMISSION TOMOGRAPHY (PET) 14POSITRON EMISSION TOMOGRAPHY/COMPUTED X-RAY TOMOGRAPHY(PET/CT) 15SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 15USES AND DEMAND FOR MI DEVICES 16Aging 16TYPES OF MOLECULAR IMAGING DEVICES 16TABLE 2 TYPES OF MOLECULAR IMAGING SCANNERS 17STAND-ALONE PLANAR IMAGING 17PET 17PET-CT 18SPECT 18SPECT-CT 19APPLICATIONS OF MOLECULAR IMAGING 19ONCOLOGY DEMOGRAPHICS 19TABLE 3 OVERALL CANCER RATES BY COUNTRY, 2013 20CARDIOVASCULAR DISEASE DEMOGRAPHICS 21TABLE 4 HEART DISEASE DEATHS BY COUNTRY, 2013 22NEUROLOGICAL DISEASE DEMOGRAPHICS 23RESPIRATORY DISEASE DEMOGRAPHICS 23GLOBAL BURDEN OF DISEASES 24TABLE 5 GLOBAL LEADING CAUSES OF DISEASE BURDEN 1990 AND 2020 25TABLE 6 GLOBAL MAJOR CAUSES OF CANCER DEATHS ESTIMATED IN 2013 25TABLE 7 GLOBAL POPULATION BY CONTINENT OR REGION, 2011 26TABLE 8 WORLD POPULATION-10 MOST POPULOUS COUNTRIES, 2013 26TABLE 9 COUNTRY RANKING POPULATION (PLUS 15 MILLION) AND DENSITY (PLUS250 PEOPLE KM2) 27TABLE 10 UN 2012 ESTIMATES AND MEDIUM VARIANT PROJECTIONS (MILLIONS/%) 27TABLE 11 WORLD HISTORICAL AND PREDICTED POPULATIONS BY YEAR ANDREGION, 1500-2150 (%)* 28PRICING ANALYSIS 29TABLE 12 AVERAGE SELLING PRICE OF MOLECULAR IMAGING DEVICES BY TYPE,THROUGH 2018 ($) 30CHAPTER 4 GLOBAL MARKET SIZE AND GROWTH 32TREND TOWARDS PERSONALIZED MEDICINE 32TABLE 13 GLOBAL MARKET AND GROWTH BY REGION FOR MOLECULAR IMAGINGDEVICES BY REGION, THROUGH 2018 ($ MILLIONS) 34FIGURE 1 GLOBAL MARKET AND GROWTH BY REGION FOR MOLECULAR IMAGINGDEVICES BY REGION, 2012-2018 ($ MILLIONS) 34GROWTH BY GEOGRAPHIC REGION 35TABLE 14 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BYREGION, 2013 (%) 37FIGURE 2 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BYREGION, 2013 (%) 37TABLE 15 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BYREGION, 2018 (%) 38FIGURE 3 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BYREGION, 2018 (%) 38GROWTH BY DEVICE TYPE 38TABLE 16 GLOBAL REVENUES FOR MOLECULAR IMAGING DEVICES BY TYPE ATMANUFACTURERS' SALES LEVELS THROUGH 2018 ($ MILLIONS) 39FIGURE 4 GLOBAL REVENUES FOR MOLECULAR IMAGING DEVICES BY TYPE ATMANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 39TABLE 17 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 40FIGURE 5 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 40TABLE 18 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 41FIGURE 6 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 41GROWTH BY APPLICATION 42ALZHEIMER'S DISEASE 42CARDIOLOGY, ONCOLOGY AND NEUROLOGY 42TECHNOLOGY 43COMPETITIVE ANALYSIS 43TABLE 19 GLOBAL MOLECULAR IMAGING DEVICE MARKET COMPETITIVE ANALYSIS,2013 ($ MILLIONS/%) 44FIGURE 7 GLOBAL MOLECULAR IMAGING DEVICE MARKET COMPETITIVE ANALYSIS,2013 (%) 44CHAPTER 5 GLOBAL MARKET BY DEVICE TYPE AND APPLICATION 46PLANAR SCINTILLATION CAMERAS 46TABLE 20 GLOBAL MARKET FOR PLANAR SCINTILLATION CAMERAS ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 46FIGURE 8 GLOBAL MARKET FOR PLANAR SCINTILLATION CAMERAS ATMANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 47PET SCANNERS 47TABLE 21 GLOBAL MARKET FOR PET SCANNERS AT MANUFACTURERS' SALESLEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 47FIGURE 9 GLOBAL MARKET FOR PET SCANNERS AT MANUFACTURERS' SALESLEVELS, 2012-2018 ($ MILLIONS) 47PET/CT SCANNERS 48TABLE 22 GLOBAL MARKET FOR PET/CT SCANNERS AT MANUFACTURERS' SALESLEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 49FIGURE 10 GLOBAL MARKET FOR PET/CT SCANNERS AT MANUFACTURER'S SALESLEVELS, 2012-2018 ($ MILLIONS) 49SPECT SCANNERS 49TABLE 23 GLOBAL MARKET FOR SPECT SCANNERS AT MANUFACTURERS' SALESLEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 50FIGURE 11 GLOBAL MARKET FOR SPECT SCANNERS AT MANUFACTURERS' SALESLEVELS, 2012-2018 ($ MILLIONS) 50SPECT/CT SCANNERS 50TABLE 24 GLOBAL MARKET FOR SPECT/CT SCANNERS, THROUGH 2018 ($MILLIONS/UNITS) 51FIGURE 12 GLOBAL MARKET FOR SPECT/CT SCANNERS, 2012-2018 ($ MILLIONS) 51STAND-ALONE PET SCANNERS 51TABLE 25 GLOBAL MARKET FOR STAND-ALONE PET SCANNERS ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 52FIGURE 13 GLOBAL MARKET FOR STAND-ALONE PET SCANNERS ATMANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 52STAND-ALONE SPECT SCANNERS 52TABLE 26 GLOBAL MARKET FOR STAND-ALONE SPECT SCANNERS ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 53FIGURE 14 GLOBAL MARKET FOR STAND-ALONE SPECT SCANNERS ATMANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 53THE MARKET BY APPLICATION 53ONCOLOGY 53CARDIOLOGY AND VASCULAR APPLICATIONS 54NEUROLOGY 54CHAPTER 6 INDUSTRY STRUCTURE, TECHNOLOGY TRENDS: FUSION TECHNOLOGIES AND MARKET SHARE 56INTRODUCTION 56MARKET DRIVERS AND MARKET RESTRAINTS 57TABLE 27 MOLECULAR IMAGING DEVICE MARKET DRIVERS BY IMPACT, 2013THROUGH 2018 59TABLE 28 MOLECULAR IMAGING DEVICE MARKET RESTRAINTS BY IMPACT, 2013THROUGH 2018 59INDUSTRY CHALLENGES 59TECHNOLOGY TRENDS: FUSION TECHNOLOGIES 61HYBRID PET/MR AND SPECT/MR 654D-PET/MRI 65NANOBIOTECHNOLOGY 65CLOUD COMPUTING 66TABLE 29 SECTRA PACS CLOUD COMPUTING PACKAGES 67TABLE 30 MAIN CLOUD PROVIDERS 67TABLE 31 PACS CLOUD SYSTEM PROVIDERS 68TABLE 32 ZERO-DOWNLOAD SYSTEM PROVIDERS 70MARKET SHARE ANALYSIS 70INTRODUCTION 70SIEMENS 70GE 71Overall Segments 71GE Healthcare 71PHILIPS 72Overall Segments 72Healthcare 72HITACHI 73Overall Segments 73TABLE 33 HITACHI MARKET BY REGION ($ MILLIONS) 73TOSHIBA CORPORATION 74Overall Segments 74CHAPTER 7 PATENT ANALYSIS 76THE IMPORTANCE OF A PATENT - A HISTORY IN BRIEF 76PATENT COOPERATION TREATY (PCT) 76OVERVIEW OF PATENTING 77PATENT REGULATIONS IN DIFFERENT COUNTRIES 77EU PATENTS 77U.S. PATENT 77CANADIAN PATENT 78JAPANESE PATENTS 78First to File Patent Application Procedure 78CHINESE PATENTS 79INDIAN PATENTS 79BRAZILIAN PATENTS 79RUSSIAN PATENTS 80AUSTRALIAN PATENTS 80SOUTH KOREAN PATENTS 81TAIWANESE PATENTS 81RECENTLY AWARDED PATENTS IN MOLECULAR IMAGING 82PATENT STATISTICS BY COMPANY FOR 2010 83TABLE 34 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2010(NUMBER/RANKING) 83TABLE 35 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN CHINA, 2010(NUMBER/RANKING) 83PATENT STATISTICS BY COMPANY FOR 2011 83TABLE 36 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2011(NUMBER/RANKING) 83TABLE 37 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN EUROPE, 2011(NUMBER/RANKING) 84PATENT STATISTICS BY COMPANY FOR 2012 84TABLE 38 MOLECULAR IMAGING DEVICES: EUROPEAN PATENTS ISSUED, 2012(NUMBER/RANKING) 84TABLE 39 MOLECULAR IMAGING DEVICES: U.S. PATENTS ISSUED, 2012(NUMBER/RANKING) 84PATENTS BY YEAR AND ASSIGNEE 2010 THROUGH 2013 85TABLE 40 NUMBER OF PATENTS BY YEAR, 2010-2013* (NUMBER) 85TABLE 41 PET/SPECT, PET/CT, SPECT/CT SCANNER PATENTS BY ASSIGNEE,JANUARY 2010-JUNE 2012 (NUMBER/%) 86TABLE 42 RECENT MOLECULAR IMAGING DEVICE PATENTS GRANTED TO ASSIGNEEBY YEAR, 2011 AND 2012 87TABLE 43 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TOASSIGNEE BY YEAR, 2010-2013 90TABLE 44 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TOASSIGNEE BY YEAR, 2013 92TABLE 45 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TOASSIGNEE BY YEAR, 2010 AND 2013 93TABLE 46 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TOASSIGNEE BY YEAR, 2010 94TABLE 47 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TOASSIGNEE BY YEAR, 2011 95TABLE 48 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TOASSIGNEE BY YEAR, 2012 96TABLE 49 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TOASSIGNEE BY YEAR, 2013 97CHAPTER 8 REGULATIONS AND REIMBURSEMENT 99OVERVIEW 99TABLE 50 REGULATORY AGENCIES BY COUNTRY 99GLOBAL HARMONIZATION TASK FORCE (GHTF) 100MEDICAL DEVICE REGULATIONS BY REGION/COUNTRY 100EUROPEAN UNION 100UNITED STATES 101CANADA 101JAPAN 102PAL Classifications 103CHINA 103INDIA 104BRAZIL 105RUSSIA 105AUSTRALIA 106MEXICO 107SOUTH KOREA 108TAIWAN 108REIMBURSEMENT CHALLENGES 109OVERVIEW OF REIMBURSEMENT PROCEDURES BY REGION/COUNTRY 110EUROPEAN UNION 110UNITED STATES 110CANADA 111JAPAN 111CHINA 112INDIA 112BRAZIL 113RUSSIA 113AUSTRALIA 113MEXICO 114SOUTH KOREA 114TAIWAN 114MOLECULAR IMAGING DEVICES REGULATIONS IN GENERAL 115FUTURE TECHNOLOGICAL DEVELOPMENTS 115CHAPTER 9 THE NORTH AMERICAN MARKET 117UNITED STATES 117UNITED STATES: ELDERLY POPULATION DEMOGRAPHICS 118TABLE 51 OLDER POPULATION IN THE U.S. BY AGE GROUP 2000-2050 119CANADA 119CANADA: ELDERLY POPULATION DEMOGRAPHICS 119TABLE 52 OLDER POPULATION IN CANADA BY AGE GROUP, 2000-2050 120THE AMERICAS: MARKET SIZE AND GROWTH OF THE MOLECULAR IMAGINGSCANNERS MARKET 120TABLE 53 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 121FIGURE 15 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION ATMANUFACTURERS' SALES LEVELS, 2013 ($ MILLIONS) 121FIGURE 16 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION ATMANUFACTURERS' SALES LEVELS, 2018 ($ MILLIONS) 122TABLE 54 MOLECULAR IMAGING DEVICES BY TYPE AT MANUFACTURERS' SALESLEVELS IN THE AMERICAS, THROUGH 2018 ($ MILLIONS) 123FIGURE 17 MARKET FOR MOLECULAR IMAGING DEVICES BY TYPE ATMANUFACTURERS' SALES LEVELS IN THE AMERICAS, 2012-2018 ($ MILLIONS) 123TABLE 55 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THEAMERICAS, 2013 (%) 124FIGURE 18 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THEAMERICAS, 2013 (%) 124TABLE 56 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THEAMERICAS, 2018 (%) 125FIGURE 19 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THEAMERICAS, 2018 (%) 125TABLE 57 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN THEAMERICAS, 2013 ($ MILLIONS/%) 126FIGURE 20 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN THEAMERICAS, 2013 (%) 126UNITED STATES 127TABLE 58 U.S. MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH 2018 ($MILLIONS) 128FIGURE 21 U.S. MARKET FOR MOLECULAR IMAGING DEVICES, 2012-2018 ($MILLIONS) 128TABLE 59 U.S. REGIONAL BREAKDOWN BY MOLECULAR IMAGING DEVICE TYPE,THROUGH 2018 ($ MILLIONS) 129FIGURE 22 U.S. REGIONAL BREAKDOWN BY MOLECULAR IMAGING DEVICE TYPE,2013 AND 2018 ($ MILLIONS) 129CANADA 130TABLE 60 MARKET FOR MOLECULAR IMAGING DEVICES IN CANADA, THROUGH2018 ($ MILLIONS/UNITS) 130FIGURE 23 MARKET FOR MOLECULAR IMAGING DEVICES IN CANADA, 2012-2018 ($MILLIONS) 131TABLE 61 REVENUE FOR MOLECULAR IMAGING DEVICES IN CANADA BY TYPE,THROUGH 2018 ($ MILLIONS) 132FIGURE 24 CANADIAN REVENUE BY MOLECULAR IMAGING DEVICE TYPE, 2013 AND2018 ($ MILLIONS) 132CHAPTER 10 THE EUROPEAN MARKET 135EUROPEAN ELDERLY POPULATION DEMOGRAPHICS 136FRANCE 137France's Elderly Demographics 137TABLE 62 FRANCE'S OLDER POPULATION BY AGE GROUP 2000-2050 138GERMANY 138Germany's Elderly Demographics 139TABLE 63 GERMANY'S OLDER POPULATION BY AGE GROUP, 2000-2050 139ITALY 140Italy's Elderly Demographics 140TABLE 64 ITALY'S OLDER POPULATION BY AGE GROUP 2000-2050 141SPAIN 141Spain's Elderly Demographics 142TABLE 65 SPAIN'S OLDER POPULATION BY AGE GROUP, 2000-2050 142UNITED KINGDOM 142U.K.'S Elderly Demographics 143TABLE 66 U.K.'S OLDER POPULATION BY AGE GROUP 2000-2050 143BENELUX 144The Netherlands Elderly Demographics 146TABLE 67 THE NETHERLANDS' OLDER POPULATION BY AGE GROUP, 2000-2050 146Belgium's Elderly Demographics 146TABLE 68 BELGIUM'S OLDER POPULATION BY AGE GROUP, 2000-2050 147Luxembourg's Elderly Demographics 147TABLE 69 LUXEMBOURG'S OLDER POPULATION BY AGE GROUP 2000-2050 148SCANDINAVIA 148Denmark's Elderly Demographics 149TABLE 70 DENMARK'S OLDER POPULATION BY AGE GROUP 2000-2050 149Norway's Elderly Demographics 150TABLE 71 NORWAY'S OLDER POPULATION BY AGE GROUP 2000-2050 151Sweden's Elderly Demographics 151TABLE 72 SWEDEN'S OLDER POPULATION BY AGE GROUP, 2000-2050 152EUROPEAN MOLECULAR IMAGING DEVICES MARKET SIZE AND GROWTH 152TABLE 73 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY REGION ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 154FIGURE 25 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY REGION ATMANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 155TABLE 74 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY TYPE ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 156FIGURE 26 MOL文件倉CULAR IMAGING DEVICE MARKET IN EUROPE BY TYPE ATMANUFACTURERS' SALES LEVELS, 2012-2018 ($ MILLIONS) 156TABLE 75 MOLECULAR IMAGING DEVICE MARKET SHARE BY TYPE, 2013 (%) 157FIGURE 27 MOLECULAR IMAGING DEVICE MARKET SHARE IN EUROPE BY TYPE,2013 (%) 157TABLE 76 MOLECULAR IMAGING DEVICE MARKET SHARE IN EUROPE BY TYPE, 2018(%) 158FIGURE 28 MOLECULAR IMAGING DEVICE MARKET SHARE BY TYPE, 2018 (%) 159EUROPEAN MOLECULAR IMAGING DEVICE MARKET: APPLICATIONS 159EUROPEAN MOLECULAR IMAGING DEVICE MARKET: COMPANY 159TABLE 77 EUROPEAN MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY,2013 (%) 160FIGURE 29 EUROPEAN MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY,2013 (%) 160FRANCE 161TABLE 78 MARKET FOR MOLECULAR IMAGING DEVICES IN FRANCE, THROUGH2018 161FIGURE 30 MARKET FOR MOLECULAR IMAGING DEVICES IN FRANCE, 2012-2018 ($MILLIONS) 161TABLE 79 MOLECULAR IMAGING DEVICES REVENUE BY TYPE IN FRANCE, THROUGH2018 ($ MILLIONS) 162FIGURE 31 MOLECULAR IMAGING DEVICES REVENUE BY TYPE IN FRANCE, 2013AND 2018 ($ MILLIONS) 162GERMANY 163TABLE 80 MARKET FOR MOLECULAR IMAGING DEVICES IN GERMANY, THROUGH2018 ($ MILLIONS/UNITS) 163FIGURE 32 MARKET FOR MOLECULAR IMAGING DEVICES IN GERMANY, 2012-2018($ MILLIONS) 163TABLE 81 MOLECULAR IMAGING REVENUE BY DEVICE IN GERMANY, 2013 AND2018 ($ MILLIONS) 164FIGURE 33 MOLECULAR IMAGING REVENUE BY DEVICE IN GERMANY, 2013 AND2018 ($ MILLIONS) 164ITALY 165TABLE 82 MARKET FOR MOLECULAR IMAGING DEVICES IN ITALY, THROUGH 2018($ MILLIONS/UNITS) 165FIGURE 34 MARKET FOR MOLECULAR IMAGING DEVICES IN ITALY, 2012-2018 ($MILLIONS) 165TABLE 83 MOLECULAR IMAGING REVENUE BY DEVICE IN ITALY, 2013 AND 2018 ($MILLIONS) 166FIGURE 35 MOLECULAR IMAGING REVENUE BY DEVICE IN ITALY, 2013 AND 2018 ($MILLIONS) 166SPAIN 167TABLE 84 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, THROUGH 2018($ MILLIONS/UNITS) 167FIGURE 36 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, 2012-2018 ($MILLIONS) 167TABLE 85 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, THROUGH2018 ($ MILLIONS) 168FIGURE 37 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, 2013-2018($ MILLIONS) 168UNITED KINGDOM 169TABLE 86 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., THROUGH2018 ($ MILLIONS/UNITS) 169FIGURE 38 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., 2012-2018 ($MILLIONS) 169TABLE 87 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND 2018($ MILLIONS) 170FIGURE 39 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND2018 ($ MILLIONS) 170SCANDINAVIA 171TABLE 88 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIAREGION, THROUGH 2018 ($ MILLIONS/UNITS) 171FIGURE 40 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIAREGION, 2012-2018 ($ MILLIONS) 171TABLE 89 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIAREGION, 2013 AND 2018 ($ MILLIONS) 172FIGURE 41 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIAREGION, 2013-2018 ($ MILLIONS) 172BENELUX 173TABLE 90 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,THROUGH 2018 ($ MILLIONS/UNITS) 173FIGURE 42 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,2012-2018 ($ MILLIONS) 173TABLE 91 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,2013 AND 2018 ($ MILLIONS) 175FIGURE 43 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,2013 AND 2018 ($ MILLIONS) 175CHAPTER 11 THE ASIAN MARKET 177OVERVIEW 177THE ASIAN MARKET 177INDIA 178TABLE 92 HEALTHCARE GOALS BY YEAR 179India's Elderly Population Demographics 180TABLE 93 INDIA'S POPULATION DEMOGRAPHIC FIGURES FOR 2013 180TABLE 94 INDIA'S OLDER POPULATION BY AGE GROUP 2000-2050 181JAPAN 181Japan's Elderly Population Demographics 182TABLE 95 JAPAN'S OLDER POPULATION BY AGE GROUP 2000-2050 182CHINA 183China's Elderly Population Demographics 183TABLE 96 CHINA'S OLDER POPULATION BY AGE GROUP, 2000-2050 184MARKET FOR MOLECULAR IMAGING SCANNERS IN ASIA 184TABLE 97 CONTRIBUTIONS BY EMERGING ECONOMIES INTO A CENTRAL FUND ($BILLIONS) 184TABLE 98 MARKET FOR MOLECULAR IMAGING SCANNERS BY GEOGRAPHIC REGIONAT MANUFACTURERS' SALES LEVELS IN ASIA, THROUGH 2018 ($ MILLIONS) 184FIGURE 44 MARKET FOR MOLECULAR IMAGING SCANNERS BY GEOGRAPHICREGION AT MANUFACTURERS' SALES LEVELS IN ASIA, 2012-2018 ($ MILLIONS) 185TABLE 99 MARKET FOR MOLECULAR IMAGING DEVICES IN ASIA BY TYPE ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 186FIGURE 45 MARKET FOR MOLECULAR IMAGING SCANNERS BY DEVICE ATMANUFACTURERS' SALES LEVELS IN ASIA, 2012-2018 ($ MILLIONS) 186TABLE 100 ASIAN MOLECULAR IMAGING MARKET BY DEVICE 2013 (%) 187FIGURE 46 ASIAN MOLECULAR IMAGING MARKET BY DEVICE TYPE 2013 (%) 187TABLE 101 ASIAN MOLECULAR IMAGING MARKET BY DEVICE TYPE, 2018 (%) 188FIGURE 47 ASIAN MOLECULAR IMAGING MARKET BY DEVICE TYPE, 2018 (%) 188TABLE 102 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN ASIA,2013 ($ MILLIONS/%) 189FIGURE 48 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN ASIA,2013 (%) 189INDIA 190TABLE 103 MARKET FOR MOLECULAR IMAGING DEVICES IN INDIA, THROUGH 2018($ MILLIONS/UNITS) 190FIGURE 49 MARKET FOR MOLECULAR IMAGING DEVICES IN INDIA, 2012-2018 ($MILLIONS) 190TABLE 104 REVENUE BY MOLECULAR IMAGING DEVICE IN INDIA, THROUGH 2018($ MILLIONS) 191FIGURE 50 REVENUE BY MOLECULAR IMAGING DEVICE IN INDIA, 2013 AND 2018 ($MILLIONS) 191CHINA 192TABLE 105 MARKET FOR MOLECULAR IMAGING DEVICES IN CHINA THROUGH 2018($ MILLIONS/UNITS) 192FIGURE 51 MARKET FOR MOLECULAR IMAGING DEVICES IN CHINA, 2012-2018 ($MILLIONS) 192TABLE 106 REVENUE BY MOLECULAR IMAGING DEVICE IN CHINA, 2013 AND 2018($ MILLIONS) 193FIGURE 52 REVENUE FOR MOLECULAR IMAGING DEVICES IN CHINA, 2013 AND2018 ($ MILLIONS) 193JAPAN 193TABLE 107 MARKET FOR MOLECULAR IMAGING DEVICES IN JAPAN, THROUGH 2018($ MILLIONS/UNITS) 194FIGURE 53 MARKET FOR MOLECULAR IMAGING DEVICES IN JAPAN 2012-2018 ($MILLIONS) 194TABLE 108 REVENUE FOR MOLECULAR IMAGING DEVICES IN JAPAN, 2013 AND2018 ($ MILLIONS) 195FIGURE 54 REVENUE FOR MOLECULAR IMAGING DEVICES IN JAPAN 2013 AND 2018($ MILLIONS) 195CHAPTER 12 EMERGING MARKETS 197AUSTRALIA 197AUSTRALIA'S ELDERLY POPULATION DEMOGRAPHICS 198TABLE 109 AUSTRALIA'S OLDER POPULATION BY AGE GROUP, 2000-2050 198BRAZIL 198BRAZIL'S ELDERLY POPULATION DEMOGRAPHICS 199TABLE 110 BRAZIL'S OLDER POPULATION BY AGE GROUP 2000-2050 200ISRAEL 200ISRAEL'S ELDERLY POPULATION DEMOGRAPHICS 201TABLE 111 ISRAEL'S OLDER POPULATION BY AGE GROUP, 2000-2050 201RUSSIA 201RUSSIA'S ELDERLY POPULATION DEMOGRAPHICS 202TABLE 112 RUSSIA'S OLDER POPULATION BY AGE GROUP, 2000-2050 203MARKET FOR MOLECULAR IMAGING SCANNERS IN EMERGING COUNTRIES 203TABLE 113 MARKET FOR MOLECULAR IMAGING DEVICES BY REGION ATMANUFACTURERS' SALES LEVELS IN EMERGING MARKETS, THROUGH 2018 ($MILLIONS)204FIGURE 55 MARKET FOR MOLECULAR IMAGING DEVICES BY REGION ATMANUFACTURERS' SALES LEVELS IN EMERGING MARKETS, 2012-2018 ($ MILLIONS) 205TABLE 114 EMERGING MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 205TABLE 115 MARKET FOR MOLECULAR IMAGING DEVICES BY TYPE ATMANUFACTURERS' SALES LEVELS IN EMERGING MARKETS, THROUGH 2018 ($MILLIONS)206FIGURE 56 MARKET FOR MOLECULAR IMAGING DEVICES BY TYPE ATMANUFACTURERS' SALES LEVELS IN EMERGING MARKET 2012-2018 ($ MILLIONS) 206TABLE 116 EMERGING MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 207FIGURE 57 EMERGING MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 207TABLE 117 MARKET FOR MOLECULAR IMAGING DEVICES IN EMERGING MARKETSBY COMPANY, 2013 ($ MILLIONS/%) 208FIGURE 58 MARKET FOR MOLECULAR IMAGING DEVICES IN EMERGING MARKETSBY COMPANY, 2013 (%) 208AUSTRALIA 209TABLE 118 MARKET FOR MOLECULAR IMAGING DEVICES IN AUSTRALIA, THROUGH2018 ($ MILLIONS/%) 209FIGURE 59 MARKET FOR MOLECULAR IMAGING DEVICES IN AUSTRALIA, 2012-2018($ MILLIONS) 209TABLE 119 REVENUE FOR MOLECULAR IMAGING DEVICES BY TYPE IN AUSTRALIA,THROUGH 2018 ($ MILLIONS) 210FIGURE 60 REVENUE FOR MOLECULAR IMAGING DEVICES BY TYPE IN AUSTRALIA,2013 AND 2018 ($ MILLIONS) 210BRAZIL 210TABLE 120 MARKET FOR MOLECULAR IMAGING DEVICES IN BRAZIL, THROUGH2018 ($ MILLIONS/UNITS) 211FIGURE 61 MARKET FOR MOLECULAR IMAGING DEVICES IN BRAZIL, 2012-2018 ($MILLIONS) 211TABLE 121 REVENUE FOR MOLECULAR IMAGING DEVICES IN BRAZIL, THROUGH2018 ($ MILLIONS) 212FIGURE 62 REVENUE FOR MOLECULAR IMAGING DEVICES IN BRAZIL, 2013 AND2018 ($ MILLIONS) 212ISRAEL 213TABLE 122 MARKET FOR MOLECULAR IMAGING DEVICES IN ISRAEL, THROUGH2018 ($ MILLIONS/UNITS) 213FIGURE 63 MARKET FOR MOLECULAR IMAGING DEVICES IN ISRAEL, 2012-2018 ($MILLIONS) 214TABLE 123 REVENUE FOR MOLECULAR IMAGING DEVICES IN ISRAEL BY TYPE,THROUGH 2018 ($ MILLIONS) 214FIGURE 64 REVENUE FOR MOLECULAR IMAGING DEVICES IN ISRAEL BY TYPE, 2013AND 2018 ($ MILLIONS) 215RUSSIA 215TABLE 124 MARKET FOR MOLECULAR IMAGING DEVICES IN RUSSIA, THROUGH2018 ($ MILLIONS/UNITS) 216FIGURE 65 MARKET FOR MOLECULAR IMAGING DEVICES IN RUSSIA, 2012-2018 ($MILLIONS) 216TABLE 125 REVENUE FOR MOLECULAR IMAGING DEVICES IN RUSSIA BY TYPE,THROUGH 2018 ($ MILLIONS) 217FIGURE 66 REVENUE FOR MOLECULAR IMAGING DEVICES IN RUSSIA BY TYPE, 2013AND 2018 ($ MILLIONS) 217CHAPTER 13 MARKET STRATEGIES STRATEGIC RECOMMENDATIONS 220SUGGESTED STRATEGIES - A GENERAL OVERVIEW 220EMPLOY A MARKETING COMPANY 220INCREASED EXPOSURE 220COMPETITIVE DEVICES AND PRICING 221TABLE 126 HEALTHCARE SERVICES, COMPARED BY COUNTRY 221R&D - PATIENT POWER 222PATENTING STRATEGIES 222ADDRESSING THE PRIMARY CONCERNS 223PRIMARY CONCERNS: 223Primary Concerns: Numbers 1 through 5: 223Primary Concerns: Numbers 6 through 8 225Mobile Units 226Primary Concerns: Numbers 9 and 10 226TABLE 127 AVERAGE DOSE MDP-SPECT 227TABLE 128 AVERAGE DOSE FDG-PET 228Primary Concern: Number 11 228Primary Concern: Number 12 229Primary Concern: Number 13 230CHAPTER 14 COMPANY PROFILES 233MOLECULAR IMAGING OVERVIEW 233MARKET DRIVERS 233CHALLENGES 233A REVIEW OF INDIVIDUAL COMPANIES 234CARDIARC 234Overview 234Highlights 235Segments 235Products 235DIGIRAD 235Overview 235Highlights 235Segments 235Products 236DILON DIAGNOSTICS 236Overview 236Highlights 236Segments 236Products 236GAMMA MEDICA INC. 237Overview 237Highlights 237Segments 237Products 237GE HEALTHCARE 237Overview 238Highlights 238Segments 238Products 238GVI MEDICAL DEVICES 239Overview 239Highlights 239Segments 239Products 239HITACHI MEDICAL SYSTEMS 239Overview 239Highlights 240Segments 240Products 240MEDISO IMAGING SYSTEMS 240Overview 240Highlights 241Segments 241Products 241NAVISCAN 241Overview 241Highlights 242Segments 242Products 242NEUROLOGICA CORPORATION 242Overview 242Highlights 242Segments 243Products 243NEUSOFT MEDICAL LTD 243Overview 243Highlights 243Segments 243Products 244NUCLEAR CARDIOLOGY SYSTEMS 244Overview 244Highlights 244Segments 244Products 245PHILIPS MEDICAL SYSTEMS 245Overview 245Highlights 245TABLE 129 PHILIPS MEDICAL SYSTEMS AWARDS 246Segments 246Products 246POSITRON CORPORATION 246Overview 246Highlights 247Segments 247Products 247SIEMENS HEALTHCARE 247Overview 248Highlights 248Segments 248Products 248SPECTRUM DYNAMICS 248Overview 249Highlights 249Segments 249Products 249TOSHIBA MEDICAL SYSTEMS 249Overview 249TABLE 130 GOVERNMENT ANNUAL CONTRACTS AWARDED 250Highlights 250Segments 250Products 250TRIVITRON HEALTHCARE 250Overview 251Highlights 251Segments 251Products 251ACQUISITIONS AND ALLIANCES 252TABLE 131 NEUSOFT MEDICAL STRATEGIC ACQUISITIONS AND ALLIANCES, 2012 252TABLE 132 GE HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES 1998-2012 252TABLE 133 NEUROLOGICA CORP STRATEGIC ACQUISITIONS AND ALLIANCES, 2012 253TABLE 134 PHILIPS HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES,1998-2012 253TABLE 135 SIEMENS HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES2006 AND 2007 253TABLE 136 TOSHIBA MEDICAL SYSTEMS STRATEGIC ACQUISITIONS AND ALLIANCES,2003-2009 254TABLE 137 TRIVITRON HEALTHCARE STRATEGIC ACQUISITIONS AND ALLIANCES,1998-2012 254LIST OF TABLESSUMMARY TABLE GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH2018 ($ MILLIONS) 7TABLE 1 CURRENT PROCESSORS OF MO-99 BY COUNTRY 14TABLE 2 TYPES OF MOLECULAR IMAGING SCANNERS 17TABLE 3 OVERALL CANCER RATES BY COUNTRY, 2013 20TABLE 4 HEART DISEASE DEATHS BY COUNTRY, 2013 22TABLE 5 GLOBAL LEADING CAUSES OF DISEASE BURDEN 1990 AND 2020 25TABLE 6 GLOBAL MAJOR CAUSES OF CANCER DEATHS ESTIMATED IN 2013 25TABLE 7 GLOBAL POPULATION BY CONTINENT OR REGION, 2011 26TABLE 8 WORLD POPULATION-10 MOST POPULOUS COUNTRIES, 2013 26TABLE 9 COUNTRY RANKING POPULATION (PLUS 15 MILLION) AND DENSITY (PLUS250 PEOPLE KM2) 27TABLE 10 UN 2012 ESTIMATES AND MEDIUM VARIANT PROJECTIONS (MILLIONS/%) 27TABLE 11 WORLD HISTORICAL AND PREDICTED POPULATIONS BY YEAR AND REGION,1500-2150 (%)* 28TABLE 12 AVERAGE SELLING PRICE OF MOLECULAR IMAGING DEVICES BY TYPE,THROUGH 2018 ($) 30TABLE 13 GLOBAL MARKET AND GROWTH BY REGION FOR MOLECULAR IMAGINGDEVICES BY REGION, THROUGH 2018 ($ MILLIONS) 34TABLE 14 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BYREGION, 2013 (%) 37TABLE 15 GLOBAL MARKET FOR MOLECULAR IMAGING DEVICES REVENUES BYREGION, 2018 (%) 38TABLE 16 GLOBAL REVENUES FOR MOLECULAR IMAGING DEVICES BY TYPE ATMANUFACTURERS' SALES LEVELS THROUGH 2018 ($ MILLIONS) 39TABLE 17 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2013 (%) 40TABLE 18 GLOBAL MOLECULAR IMAGING DEVICE MARKET BY TYPE, 2018 (%) 41TABLE 19 GLOBAL MOLECULAR IMAGING DEVICE MARKET COMPETITIVE ANALYSIS,2013 ($ MILLIONS/%) 44TABLE 20 GLOBAL MARKET FOR PLANAR SCINTILLATION CAMERAS ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 46TABLE 21 GLOBAL MARKET FOR PET SCANNERS AT MANUFACTURERS' SALESLEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 47TABLE 22 GLOBAL MARKET FOR PET/CT SCANNERS AT MANUFACTURERS' SALESLEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 49TABLE 23 GLOBAL MARKET FOR SPECT SCANNERS AT MANUFACTURERS' SALESLEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 50TABLE 24 GLOBAL MARKET FOR SPECT/CT SCANNERS, THROUGH 2018 ($MILLIONS/UNITS) 51TABLE 25 GLOBAL MARKET FOR STAND-ALONE PET SCANNERS ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 52TABLE 26 GLOBAL MARKET FOR STAND-ALONE SPECT SCANNERS ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS/UNITS) 53TABLE 27 MOLECULAR IMAGING DEVICE MARKET DRIVERS BY IMPACT, 2013THROUGH 2018 59TABLE 28 MOLECULAR IMAGING DEVICE MARKET RESTRAINTS BY IMPACT, 2013THROUGH 2018 59TABLE 29 SECTRA PACS CLOUD COMPUTING PACKAGES 67TABLE 30 MAIN CLOUD PROVIDERS 67TABLE 31 PACS CLOUD SYSTEM PROVIDERS 68TABLE 32 ZERO-DOWNLOAD SYSTEM PROVIDERS 70TABLE 33 HITACHI MARKET BY REGION ($ MILLIONS) 73TABLE 34 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2010(NUMBER/RANKING) 83TABLE 35 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN CHINA, 2010(NUMBER/RANKING) 83TABLE 36 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN THE U.S., 2011(NUMBER/RANKING) 83TABLE 37 MOLECULAR IMAGING DEVICES: PATENTS ISSUED IN EUROPE, 2011(NUMBER/RANKING) 84TABLE 38 MOLECULAR IMAGING DEVICES: EUROPEAN PATENTS ISSUED, 2012(NUMBER/RANKING) 84TABLE 39 MOLECULAR IMAGING DEVICES: U.S. PATENTS ISSUED, 2012(NUMBER/RANKING) 84TABLE 40 NUMBER OF PATENTS BY YEAR, 2010-2013* (NUMBER) 85TABLE 41 PET/SPECT, PET/CT, SPECT/CT SCANNER PATENTS BY ASSIGNEE, JANUARY2010-JUNE 2012 (NUMBER/%) 86TABLE 42 RECENT MOLECULAR IMAGING DEVICE PATENTS GRANTED TO ASSIGNEEBY YEAR, 2011 AND 2012 87TABLE 43 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEEBY YEAR, 2010-2013 90TABLE 44 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEEBY YEAR, 2013 92TABLE 45 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEEBY YEAR, 2010 AND 2013 93TABLE 46 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEEBY YEAR, 2010 94TABLE 47 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEEBY YEAR, 2011 95TABLE 48 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEEBY YEAR, 2012 96TABLE 49 RECENT MOLECULAR IMAGING DEVICES PATENTS GRANTED TO ASSIGNEEBY YEAR, 2013 97TABLE 50 REGULATORY AGENCIES BY COUNTRY 99TABLE 51 OLDER POPULATION IN THE U.S. BY AGE GROUP 2000-2050 119TABLE 52 OLDER POPULATION IN CANADA BY AGE GROUP, 2000-2050 120TABLE 53 MOLECULAR IMAGING DEVICE MARKET IN THE AMERICAS BY REGION ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 121TABLE 54 MOLECULAR IMAGING DEVICES BY TYPE AT MANUFACTURERS' SALESLEVELS IN THE AMERICAS, THROUGH 2018 ($ MILLIONS) 123TABLE 55 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE AMERICAS,2013 (%) 124TABLE 56 MOLECULAR IMAGING MARKET SHARE BY DEVICE TYPE IN THE AMERICAS,2018 (%) 125TABLE 57 MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY IN THEAMERICAS, 2013 ($ MILLIONS/%) 126TABLE 58 U.S. MARKET FOR MOLECULAR IMAGING DEVICES, THROUGH 2018 ($MILLIONS) 128TABLE 59 U.S. REGIONAL BREAKDOWN BY MOLECULAR IMAGING DEVICE TYPE,THROUGH 2018 ($ MILLIONS) 129TABLE 60 MARKET FOR MOLECULAR IMAGING DEVICES IN CANADA, THROUGH 2018($ MILLIONS/UNITS) 130TABLE 61 REVENUE FOR MOLECULAR IMAGING DEVICES IN CANADA BY TYPE,THROUGH 2018 ($ MILLIONS) 132TABLE 62 FRANCE'S OLDER POPULATION BY AGE GROUP 2000-2050 138TABLE 63 GERMANY'S OLDER POPULATION BY AGE GROUP, 2000-2050 139TABLE 64 ITALY'S OLDER POPULATION BY AGE GROUP 2000-2050 141TABLE 65 SPAIN'S OLDER POPULATION BY AGE GROUP, 2000-2050 142TABLE 66 U.K.'S OLDER POPULATION BY AGE GROUP 2000-2050 143TABLE 67 THE NETHERLANDS' OLDER POPULATION BY AGE GROUP, 2000-2050 146TABLE 68 BELGIUM'S OLDER POPULATION BY AGE GROUP, 2000-2050 147TABLE 69 LUXEMBOURG'S OLDER POPULATION BY AGE GROUP 2000-2050 148TABLE 70 DENMARK'S OLDER POPULATION BY AGE GROUP 2000-2050 149TABLE 71 NORWAY'S OLDER POPULATION BY AGE GROUP 2000-2050 151TABLE 72 SWEDEN'S OLDER POPULATION BY AGE GROUP, 2000-2050 152TABLE 73 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY REGION ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 154TABLE 74 MOLECULAR IMAGING DEVICE MARKET IN EUROPE BY TYPE ATMANUFACTURERS' SALES LEVELS, THROUGH 2018 ($ MILLIONS) 156TABLE 75 MOLECULAR IMAGING DEVICE MARKET SHARE BY TYPE, 2013 (%) 157TABLE 76 MOLECULAR IMAGING DEVICE MARKET SHARE IN EUROPE BY TYPE, 2018(%) 158TABLE 77 EUROPEAN MARKET FOR MOLECULAR IMAGING DEVICES BY COMPANY,2013 (%) 160TABLE 78 MARKET FOR MOLECULAR IMAGING DEVICES IN FRANCE, THROUGH 2018 161TABLE 79 MOLECULAR IMAGING DEVICES REVENUE BY TYPE IN FRANCE, THROUGH2018 ($ MILLIONS) 162TABLE 80 MARKET FOR MOLECULAR IMAGING DEVICES IN GERMANY, THROUGH2018 ($ MILLIONS/UNITS) 163TABLE 81 MOLECULAR IMAGING REVENUE BY DEVICE IN GERMANY, 2013 AND 2018($ MILLIONS) 164TABLE 82 MARKET FOR MOLECULAR IMAGING DEVICES IN ITALY, THROUGH 2018 ($MILLIONS/UNITS) 165TABLE 83 MOLECULAR IMAGING REVENUE BY DEVICE IN ITALY, 2013 AND 2018 ($MILLIONS) 166TABLE 84 MARKET FOR MOLECULAR IMAGING DEVICES IN SPAIN, THROUGH 2018 ($MILLIONS/UNITS) 167TABLE 85 MOLECULAR IMAGING REVENUE BY DEVICE TYPE IN SPAIN, THROUGH2018 ($ MILLIONS) 168TABLE 86 MARKET FOR MOLECULAR IMAGING DEVICES IN THE U.K., THROUGH 2018($ MILLIONS/UNITS) 169TABLE 87 MOLECULAR IMAGING REVENUE BY DEVICE IN THE U.K., 2013 AND 2018($ MILLIONS) 170TABLE 88 MARKET FOR MOLECULAR IMAGING DEVICES IN THE SCANDINAVIAREGION, THROUGH 2018 ($ MILLIONS/UNITS) 171TABLE 89 MOLECULAR IMAGING REVENUE BY DEVICE IN THE SCANDINAVIA REGION,2013 AND 2018 ($ MILLIONS) 172TABLE 90 MARKET FOR MOLECULAR IMAGING DEVICES IN THE BENELUX REGION,THROUGH 2018 ($ MILLIONS/UNITS) 173TABLE 91 MOLECULAR IMAGING REVENUE BY DEVICE IN THE BENELUX REGION,2013 AND 2018 ($ MILLIONS) 175TABLE 92 HEALTHCARE GOALS BY YEAR 179TABLE 93 INDIA'S POPULATION DEMOGRAPHIC FIGURES FOR 2013 180TABLE 94 INDIA'S OLDER POPULATION BY AGE GROUP 2000-2050 181TABLE 95 JAPAN'S OLDER POPULATION BY AGE GROUP 2To order this report: Global Markets and Technologies for Molecular Imaging Devices .reportlinker.com/p01923023/Global-Markets-and-Technologies-for-Molecular-Imaging-Devices.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging__________________________Contact Clare: clare@reportlinker.com US: (339)-368-6001Intl: +1 339-368-6001ReportlinkerWeb site: .reportlinker.com/存倉